ABSTRACT
Recently, myocardial bloodflow quantitation with dynamic SPECT has been validated to enhance the detection of multivessel coronary artery disease (CAD) and conclude equivocal SPECT myocardial perfusion study. This advance opened an important clinical
application to utilize the tool in guiding CAD management for area where
myocardial perfusion tracers for PET are unavailable or unaffordable.
We present a clinical patient with ongoing recursive angina who
underwent multiple nuclear stress tests for a sequence of CAD evaluation
in 26 months and demonstrated that SPECT myocardial bloodflow quantitation properly guided CAD management to warrant patient outcome.